Please assess the completion status of the following clinical trial:

Trial Title: Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* diagnosed with Diamond Blackfan anemia as published in British Journal of Hematology~* transfusion dependent~* age 2 years and older~* adequate renal function~* adequate liver function~* negative B-HCG if patient is a menstruating female and documentation of adequate contraception~* signed informed consent~Exclusion Criteria:~* Known hypersensitivity to branched chain amino acids~* Diagnosis of an inborn error of amino acid metabolism disorder~* Prior hematopoietic stem cell transplantation~* Pregnancy, or plans to become pregnant during duration of trial

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Leucine (Type: OTHER): No alternative treatment arm

Based on this trial design, predict the completion outcome and termination type (if applicable).